Financials Apollo Hospitals Enterprise Limited

Equities

APOLLOHOSP

INE437A01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 05:13:46 26/04/2024 pm IST			5-day change	1st Jan Change
6,259 ^INR	-1.97%		+1.44%	+9.72%

26/04	India's Apollo Hospitals' unit to raise $297 million from PE firm Advent	RE
26/04	Advent International Reportedly Queues Up for A Stake in Apollo 24/7	CI

Valuation

Fiscal Period: Maart	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	1,70,790	1,58,471	4,17,357	6,49,346	6,19,841	8,99,891	-	-
Enterprise Value (EV) ¹	2,01,137	1,85,849	4,42,681	6,60,331	6,36,264	9,27,199	9,24,344	9,17,158
P/E ratio	72.3 x	34.8 x	270 x	61.5 x	75.7 x	94.3 x	58.7 x	43.1 x
Yield	0.49%	0.53%	0.1%	0.26%	0.35%	0.21%	0.3%	0.42%
Capitalization / Revenue	1.78 x	1.41 x	3.95 x	4.43 x	3.73 x	4.7 x	4.01 x	3.41 x
EV / Revenue	2.09 x	1.65 x	4.19 x	4.5 x	3.83 x	4.84 x	4.12 x	3.47 x
EV / EBITDA	18.9 x	11.7 x	38.9 x	30.2 x	31.7 x	38.2 x	29 x	23 x
EV / FCF	89 x	23.9 x	45.3 x	68.9 x	256 x	107 x	77.2 x	56.3 x
FCF Yield	1.12%	4.19%	2.21%	1.45%	0.39%	0.94%	1.3%	1.78%
Price to Book	5.12 x	4.75 x	9.07 x	11.5 x	10 x	12.9 x	10.9 x	8.95 x
Nbr of stocks (in thousands)	1,39,125	1,39,125	1,43,785	1,43,785	1,43,785	1,43,785	-	-
Reference price ²	1,228	1,139	2,903	4,516	4,311	6,259	6,259	6,259
Announcement Date	30/05/19	25/06/20	23/06/21	25/05/22	30/05/23	-	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	96,174	1,12,468	1,05,600	1,46,626	1,66,124	1,91,599	2,24,467	2,64,064
EBITDA ¹	10,637	15,873	11,374	21,851	20,065	24,289	31,906	39,950
EBIT ¹	6,681	9,676	5,643	15,844	13,912	17,749	24,564	32,125
Operating Margin	6.95%	8.6%	5.34%	10.81%	8.37%	9.26%	10.94%	12.17%
Earnings before Tax (EBT) ¹	3,726	6,601	2,215	15,854	11,008	14,284	22,120	29,984
Net income ¹	2,360	4,549	1,504	10,556	8,191	9,649	15,249	20,740
Net margin	2.45%	4.05%	1.42%	7.2%	4.93%	5.04%	6.79%	7.85%
EPS ²	16.97	32.70	10.74	73.42	56.97	66.37	106.6	145.3
Free Cash Flow ¹	2,260	7,780	9,780	9,585	2,485	8,690	11,974	16,288
FCF margin	2.35%	6.92%	9.26%	6.54%	1.5%	4.54%	5.33%	6.17%
FCF Conversion (EBITDA)	21.25%	49.01%	85.98%	43.86%	12.39%	35.78%	37.53%	40.77%
FCF Conversion (Net income)	95.75%	171.01%	650.43%	90.8%	30.34%	90.06%	78.52%	78.54%
Dividend per Share ²	6.000	6.000	3.000	11.75	15.00	13.24	18.77	26.04
Announcement Date	30/05/19	25/06/20	23/06/21	25/05/22	30/05/23	-	-	-

¹INR in Million²INR

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1
Net sales ¹	27,598	28,680	37,602	37,171	36,389	35,464	37,956	42,511	42,636	43,022	44,178	48,163	48,265	49,348	52,180
EBITDA ¹	3,903	4,118	5,199	6,150	5,870	4,632	4,907	5,654	5,054	4,917	5,090	6,129	6,147	6,459	-
EBIT ¹	2,653	2,734	3,793	4,702	4,380	2,968	3,430	4,104	3,520	3,327	3,421	4,538	4,491	4,939	5,931
Operating Margin	9.61%	9.53%	10.09%	12.65%	12.04%	8.37%	9.04%	9.65%	8.26%	7.73%	7.74%	9.42%	9.31%	10.01%	11.37%
Earnings before Tax (EBT) ¹	1,853	2,376	3,051	3,830	3,675	2,357	2,543	3,271	2,658	2,536	2,641	3,836	3,696	3,953	-
Net income ¹	1,304	1,678	4,893	2,478	2,284	901.4	3,171	2,040	1,535	1,445	1,666	2,556	2,477	2,660	-
Net margin	4.73%	5.85%	13.01%	6.67%	6.28%	2.54%	8.35%	4.8%	3.6%	3.36%	3.77%	5.31%	5.13%	5.39%	-
EPS ²	9.380	11.77	34.03	17.24	15.88	6.270	22.05	14.19	10.67	10.50	11.59	20.53	17.51	17.07	25.00
Dividend per Share ²	-	3.000	-	-	-	11.75	-	-	-	9.000	-	-	-	12.29	-
Announcement Date	12/02/21	23/06/21	13/08/21	12/11/21	11/02/22	25/05/22	11/08/22	10/11/22	14/02/23	30/05/23	11/08/23	-	-	-	-

¹INR in Million²INR

Estimates

Balance Sheet Analysis

Fiscal Period: March	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	30,347	27,379	25,325	10,985	16,423	27,309	24,453	17,267
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	2.853 x	1.725 x	2.227 x	0.5027 x	0.8185 x	1.124 x	0.7664 x	0.4322 x
Free Cash Flow ¹	2,260	7,780	9,780	9,585	2,485	8,690	11,974	16,288
ROE (net income / shareholders' equity)	7.17%	13.6%	3.79%	20.6%	13.9%	14.6%	19.6%	22.3%
ROA (Net income/ Total Assets)	2.65%	4.43%	1.32%	8.57%	5.91%	6.82%	10%	11.8%
Assets ¹	88,978	1,02,607	1,13,780	1,23,155	1,38,485	1,41,521	1,52,245	1,76,104
Book Value Per Share ²	240.0	240.0	320.0	393.0	431.0	483.0	576.0	699.0
Cash Flow per Share ²	65.00	92.70	91.00	112.0	95.80	99.30	157.0	192.0
Capex ¹	6,789	5,119	2,955	6,572	11,285	9,806	11,506	12,598
Capex / Sales	7.06%	4.55%	2.8%	4.48%	6.79%	5.12%	5.13%	4.77%
Announcement Date	30/05/19	25/06/20	23/06/21	25/05/22	30/05/23	-	-	-

¹INR in Million²INR

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Apollo Hospitals Enterprise Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6,259 INR

Average target price

6,987 INR

Spread / Average Target

+11.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
APOLLO HOSPITALS ENTERPRISE LIMITED	+9.72%	10.79B
AIER EYE HOSPITAL GROUP CO., LTD.	-20.16%	16.21B
BANGKOK DUSIT MEDICAL SERVICES	+4.50%	12.44B
IHH HEALTHCARE	+3.98%	11.58B
RAMSAY HEALTH CARE LIMITED	-2.19%	7.68B
MOUWASAT MEDICAL SERVICES COMPANY	+20.75%	7.2B
THE ENSIGN GROUP, INC.	+4.49%	6.67B
GLOBAL HEALTH LIMITED	+50.89%	4.66B
DALLAH HEALTHCARE COMPANY	-5.01%	4.25B
BURJEEL HOLDINGS PLC	-4.50%	4.21B

Hospitals, Clinics & Primary Care Services